CIRSE Congress – minimally invasive treatment techniques

The CIRSE (Cardiovascular and Interventional Radiological Society of Europe) Congress is one of the most important international events in the Interventional Radiology Community. Every year, the congress attracts thousands of specialists from all over the world who share experience and knowledge about the latest scientific achievements and get acquainted with the most advanced solutions and innovations of Interventional Radiology and Interventional Oncology.

This year, the CIRSE Congress was held on September 14-18 in the Portuguese city of Lisbon. The congress discussed the latest clinical trials and studies that shape the future of modern medicine and Interventional Radiology. One of the key topics of congressional discussions and presentations – minimally invasive treatment techniques – ablation of tumors, embolization of blood vessels and other important methods that will be able to replace traditional surgery in the future.

During the congress, Ambercell team met with the most important partners of the company, including Terumo, Maviq, IGEA, VARIAN and CASCINATION, with whom further opportunities for cooperation and the development of innovative solutions in the Baltic States were discussed.

The exchange of knowledge and experiences, discussions, hands-on sessions, presentations of the latest medical technologies and clinical trials at the CIRSE Congress allow doctors to apply more advanced and effective treatment methods focused on patient well-being and a more efficient, safer health care system.

Share:

Related posts

Modern women prefer minimally invasive medicine

The fundamental question in medicine remains the same: how to help the patient recover as soon as possible, more efficiently and with minimal side effects, so that he returns to normal life as soon as possible. Minimally invasive procedures are often the answer to this question, because their essence and purpose is precisely this – to ensure effective treatment with the least possible impact on the patient’s body.

Workshop on the diagnosis and treatment of pelvic full blood syndrome

One of the essential symptoms of DPS is chronic or recurrent pelvic or abdominal pain lasting more than 3-6 months. In Europe, this syndrome affects about 30% of women of reproductive age, and the most effective and less invasive treatment method for treating this disease is embolization.